Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

I see this like PRM another Bio-Co that doesn't want to sell its Tech ( OR is that they can't??? ). It's a difficult position to be in when the Execs know how good their product is but no-one else is prepared to change their work-ethic......merely nodding "That's a good idea" is rather like saving your chip-oil to run your car - when your present car uses Petrol.

[[ If these two ( and many others, the List is long!) were Retail Shops they would be operating in a town with huge unemployment issues, seasonal Zero-hour employers and their shop would be something like a rusty lock-up, behind the main drag ( so foot access only), right next to the Car-Park Lifts that broke three years ago and opposite the Toilets that were closed ten years ago due to glue-sniffing. However, they did get a 25yr lease - but even that looks expensive by today's prices.
++It's not looking too good. - and any Ann. that the execs have chosen the colour of paint for the shop roller-shutters doesn't really excite anyone. Even if that was a council-based contract to paint the shutters next-door as well it would not even get in the local papers -unless a small-ad for the excess paint... er, Grey anyone? Unused 5x 10lit. (I joke!)..]].


Still, one should be grateful that there are Execs there, earning themselves money, pensions, perks, etc. waiting for the rush.
- Just hope I don't die of boredom beforehand.

Hi Hangon,

Most of your comments will greatly upset many investors who still strongly believe in Deltex, but there is no getting away from facts.

I said a while ago that my local shop is making more profit than Deltex and the only thing that matters is 'Is the product selling' and the answer is 'No, not insufficient quantities to save the company'.

Things might and probably will change for the better, but will this change come soon enough.
The way things look it's a long shot.

Sorry Greekman, no negs intended, . . . . rather a jolt to Execs ( if any care to read, etc.), Since the sp is telling us there is little interest in this co. despite the Co believing it has a really good product....that was why I became interested, at nearly 20p!
One wonders if selling to the NHS is a cost-effective use of a Salesman's time, if the probe-sales are somewhat low ( so-called Cutbacks)* . . . Co. needs to have more machines out there ( Everywhere I hear you say!), and maybe reduce the probe-cost after they have bought 100, or similar incentive.
I'm not even sure I like the Co Name - it doesn't have a Brave New World ring about it - Closer to drain cleaner ( Oh wash my mouth - but not in Dx).

Clearly you have doubts and that's reflected in their (share) Trades.

PS * It matters not that NHS can save money-per-op. by better outcomes ( ie use probes), if the NHS Buying department is not allowed to. So, I suspect the Salesman needs to be talking to the Divisional NHS bods that set Policy,
-only IF the probes really are beneficial, as we are led to believe . . . . indeed I wonder if there has been a full assessment of the finances/Ops to prove the Case . . . . but as a very minor investor no-one asks me.
Greekman - this may yet shine, but not IMHO with the present NHS set-up. I just hope the Execs hold-on, - so I may see a tiny profit for the Trust I held, er, Hold.....Their US-training school news is good and bt a few at low prices.

EDIT (22April2015)-Energeticbuyer - that Co News is similar to one other recently - good to know the Co is selling probes, but that's what we've been expecting - indeed without this there is no point in them making probes/instruments......Let's hope this activity is likely to continue.

Morning Hangon,

No prob, I do find that it is hard not to be negative re Deltex.

Deltex today announced it has established its ninth US trainer account at a prestigious teaching hospital in Boston. This will provide training to prospective users of the Group’s advanced ODM equipment and software.

This agreement also includes the procurement of at least 500 probes for inclusion in the hospital’s 2015/16 budget year starting in October 2015. In the interim the hospital is purchasing probes on an ad hoc basis and has placed three orders of 50 probes each time over the last four months.

New research note at http://tinyurl.com/nr9n37z

Leading US hospital improves surgical outcomes with ODM.

Excellent results yet again from clinical trials, BUT the product is still only selling in dribs and drabs.

Apart from the company blowing it's trumpet a lot louder through the media which might just shame some hospitals, especially those in the UK and Europe to be more active in take up, something I have advocated many times, I don't see what else the company can do.

Nicely up on the news, problem is that without follow up contracts, the sp as usual will continue to languish.

Looking at the lack of posts, it looks like interest in this share is lower than the bank rate, which is very understandable due to the lack of firm orders of any note.

Research and trial data, no matter how positive the results are become almost meaningless without some reward from said data, become same as, same as increased sales by the trickle.

Try as I might to be upbeat, even with my token holding, how can anyone be anything but despondent.

I have been a holder for at least 10 years, with promise after promise, with the management talking the same talk with little effect, leaves me wondering how many more years before contracts take the place of trial results or at least equal in prominence.

Whenever I see a RNS, I read it with a sinking heart, expecting before I even start reading that it will be an RNS that is about anything but a contract.

Ewan Phillips said a few months ago, (or was it longer), that they would look at being more proactive toward lack of sales and that they would push more to promote their product, something I suggested years ago, but it was suggested at that time, that being too pushy could have a deterrent effect of future customers.

To date I have not seen any sign of this proposed change in tactics.

I have always followed the ' if it ain't broke, don't fix it', but to my mind the boards strategy ain't working, so it does need fixing.

Deltex have this statement by Sir David Nicholson, Chief executive of the NHS England on it's home page.

Fluid management monitoring technologies can reduce mortality rates for elective procedures, improve the quality of care for more than 800,000 patients a year, and save the NHS at least £400m annually.

Why the hell don't Deltex push this through the media highlighting the lack of action being taken against NHS Trusts in the UK re none or low take up, and yes I do appreciate that it is from other countries that sales will probable come, but if NHS Trusts took up the CardioQ en mass this could only be good for total sales, after all with such a current low take up in the UK how can confidence be shown in the product if the home country won't take it.

Greekman you have highlighted what might be the basic flaws in this ficticious Busniess:
There one discovers a failing Company Management. They are tasked with steering this business and clearly they aren't up to the job.
Either there is a Corporate failure, where they are all equally culpable, or more likely there is a core of unstoppable resistance, perhaps due to seniority or holding a large slice of shares - neither of which should be permitted to control the rigid stance of what should be flexible.

You said there had been promises of changes, at DMAG - but frankly, that's just talk - easy to say but difficult to achieve . . . what is needed, maybe is a change in Management - and PDQ. For else they will find these shares are down to penny status...with the consequence that even their generous share Bonuses... or whatever else fails to drive their efforts....will be worthless promises . . . and any thoughts of raising money for development / new products / etc. will be impossible since no-one will risk buying stock with such a feeble history.

That the business is still selling a single product ( OK, with some variations), demonstrates they have failed to find customer-needs.
I think they should steer clear of NHS - because it is not organised to discovery of new ways to make savings ( and better Outcomes for the Patients ).
All IMHO + I am a LT holder,- - - but sometimes wonder what lies ahead.

Arrgh!

Hi Hangon,

Fully agree.

Nice RNS this morning, although still no large orders.

Continual, plod, plod, plod!

Re RNS Canada,

We finaly have a RNS thats worth something, but How Much, as all it states is 'The first monitor order under the tender has been received.

The tender is initially for three years and covers a number of hospital systems across a single province.

At least they could tell us how many monitors as all this RNS does is leave us guessing!

At last another RNS that is more than a yawn.

In the USA there are a higher proportion of specialist paediatric hospitals in comparison to Europe, with a dedicated hospital for children in most of the larger cities.

Blackrock has finally given up altogether on Deltex by selling their remaining holding of 10,776,297 shares.

RNS.

Another USA hospital account added with an agreement to use a minimum of 65 probes per month.

Not knocking todays news as these are the sort of RNS's we have been waiting for, but to me things are still moving far too slowly.

We need to see many more of these type of contracts making the increase of probes in at least triple figures for the year to make much difference to Deltex's bottom line.

So all probe sales up by good figures and yet the company is haemorrhaging cash (Cash available of £1.3m (31 December 2014, £2.9m).

Even allowing for the following, they had better start moving sales far faster than they are presently achieving............. 'Revenue down £0.3m to £2.7m (2014: £3.0m) Operating loss of £2.1m (2014: operating loss of £1.5m) after planned £1.0m investments in US sales development and operational improvements, exceptional costs of £0.2m.

If sales don't improve quite drastically there will have to be yet another cash raising which will knock investment confidence even further, or they will have to look for a partner (something that as you know I and several other posters have been calling for for years.

I seem to remember that they said (can't remember when) that by year end 2015 that they would be in profit, they are a long way off that!

If todays RNS does not pull Deltex out of the mire, nothing will.

The management have to shout the results of this study as loud as they can, they must not sit back, watch and wait for people to read it, otherwise it will languish along with all those previous studies.

Come on Deltex, there is a great opportunity here, don't waste it!!!!

I now think that Deltex have reached a crossroads, they will either have to

1 Sell out.
2 Enter a partnership.
or
3 Change their tactics from passive selling to more aggressive selling.

Meanwhile as I do not see the sp dropping further due to a possibility of one of the above scenarios I have just bought a few more, something over the last few years I thought I would never do.

Is the tortoise becoming more hare!

Strangely enough as we have not had a RNS this month after a nice few since Sept, I awaited 0700 hrs this morning with anticipation, something I did not dream I would be doing regarding Deltex as several months can easily drift by without any hint of a contract.

But as this mornings RNS states, 'These are the fifth and sixth new platform programme accounts that Deltex has secured since September bringing the total number of US platform accounts to 17, including 11 new ones in the year to date'.

So credit where credits due and it looks like my top up 7 days ago might just pay off.

It is starting to look as if the company will make it good on it's own, better late than never.

Can't remember how many years since I last put a buy rec on this share!

EDIT.......Market been open 45 mins and not one single trade, just shows how the market has stopped watching Deltex, good opportunity going here.

RNS,

So investors are to be offered shares at 4p.

By the time these shares are accepted for trading I would think that there is a very good chance the shares which closed last night at 4.62p will be either on par or could be even lower.

Although I have been more positive of late than I have been for ages, I will not be taking part as I think yet another dilution of company value, is a gamble too far.

If you look at share performance over the last 2 weeks (chart attached), the shares have fallen almost 20% and the market still falling won't help steady the price.

">

Todays RNS re EIS.

No doubt this incentive will encourage some to take up shares in the offer, although I am still not tempted.